FDA official: Agency is committed to timely approval of vaccines

Published



An April 10 Manhattan Moment op-ed by Jared Meyer indicated that the Food and Drug Administration has inappropriately delayed access to and approval of a serogroup B meningococcal (or MenB) vaccine in the United States.

This assertion is false. FDA is committed both to responding rapidly to public health threats and to approving products for serious medical conditions in a timely manner.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.